U.S. Electroencephalography Devices Market Size, Product Cost Analysis and Forecast 2030

U.S. Electroencephalography Devices Market Summary

The U.S. electroencephalography (EEG) devices market size was valued at USD 348.6 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.55% from 2024 to 2030. This anticipated growth is primarily driven by the increasing burden of neurological disorders linked to modern lifestyle changes, rising incidents of traumatic brain injuries, and the surge in substance use and addiction. Additionally, the growing adoption of smart EEG devices and advanced technologies, including Artificial Intelligence (AI) and data analytics, is expected to enhance diagnostic accuracy and further contribute to the robust expansion of the EEG devices market.

In recent years, the rising prevalence of neurological disorders has become a critical concern. Conditions such as epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and chronic migraine headaches are becoming increasingly common, demanding effective diagnostic solutions. Consequently, EEG technology has gained prominence as an essential tool for monitoring brain activity and detecting abnormalities. In 2023, the U.S. electroencephalography devices market held a 29% share of the global market, underscoring the country’s prominent role in the development and adoption of EEG systems for neurological diagnostics.

Key Market Trends & Insights

• Among various product categories, the 32-channel EEG segment emerged as the market leader, accounting for the largest share of 27.44% in 2023. Its dominance is primarily attributed to high physician preference and continued technological advancements. This type of EEG system is particularly effective in identifying and monitoring neurological conditions such as Attention Deficit Hyperactivity Disorder (ADHD), Parkinson’s disease, and Alzheimer’s disease. The ability to offer precise and reliable brainwave data further strengthens its adoption rate among healthcare providers and neurologists.
• Standalone EEG devices held the largest share of 87.80% in 2023. These devices function independently without requiring additional computer systems or external software, which enhances their usability and convenience in clinical settings. Featuring built-in displays and integrated data storage capabilities, standalone devices simplify the EEG monitoring process. Their user-friendly design and operational efficiency are key factors contributing to their popularity in both hospital and outpatient environments, particularly where portability and speed of diagnosis are essential.
• Disease diagnosis applications dominated the market, holding a substantial share of 87.80% in 2023. EEG devices are widely utilized for the diagnosis of various neurological and neurodevelopmental conditions. Additionally, they are used to assess sleep-related disorders, including insomnia and sleep apnea. The ability of EEG to deliver detailed insights into brain activity helps guide clinical decisions and optimize treatment outcomes. As neurological disease burden continues to rise, the demand for effective diagnostic solutions is expected to support sustained growth in this segment.
• Hospitals represented the leading end-user segment, capturing 87.80% of the U.S. market share in 2023. EEG devices are critical assets within hospital settings, enabling clinicians to analyze and monitor brain function for a broad spectrum of neurological conditions. The availability of specialized staff and infrastructure, combined with the high volume of neurological cases, makes hospitals key consumers of EEG technology. Furthermore, ongoing investments in hospital infrastructure and the development of advanced neurodiagnostic centers are expected to further increase the adoption of EEG devices in the coming years.

Order a free sample PDF of the U.S. Electroencephalography Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 348.6 million
• 2030 Projected Market Size: USD 695.1 million
• CAGR (2024 - 2030): 10.55%

Key Companies & Market Share Insights

The U.S. registers rapid growth majorly owing to the presence of a large number of medical device companies. Some of the prominent U.S. electroencephalography device companies operating in the market include Natus Medical, Inc., Electrical Geodesics, Inc., Medtronic, NeuroWave Systems, Inc., Compumedics Ltd., and Emotiv.

Furthermore, strategic initiatives undertaken by these companies to strengthen the product portfolio, a wide presence of key companies, and their multichannel offerings are expected to drive market growth.

Key Players

• Natus Medical, Inc.
• Electrical Geodesics, Inc.
• Medtronic
• NeuroWave Systems, Inc.
• Compumedics Ltd.
• Noraxon U.S.A., Inc.
• Cadwell Laboratories, Inc.
• Nihon Kohden America, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. electroencephalography devices market is poised for sustained growth due to the increasing prevalence of neurological disorders, enhanced diagnostic capabilities, and the integration of advanced technologies such as AI and data analytics. As the healthcare system evolves to meet the challenges posed by neurological and sleep-related disorders, EEG devices are becoming essential tools in diagnosis and treatment planning. High adoption rates among hospitals and preference for standalone systems support this trend. With a solid foundation in clinical efficacy and technological innovation, the EEG market is set to remain a critical component in neurodiagnostic care across the country.